Hepatic arterial infusion (HAI) of fixed dose rate gemcitabine in patients with liver metastases from colorectal carcinoma. A phase I study with pharmocokinetic analysis

被引：0
|
作者：
Leonard, Gregory D. [1 ]
Sperber, Daniella [1 ]
O'Connor, Owen [1 ]
Kemeny, Nancy E. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：245 / 245
页数：1
相关论文
共 50 条
  • [21] Hepatic resection after hepatic arterial infusion chemotherapy for initially unresectable liver metastases from colorectal carcinoma
    Fujimoto, Y
    Akasu, T
    Yamamoto, S
    Fujita, S
    Yoshihiro, M
    DISEASES OF THE COLON & RECTUM, 2004, 47 (06) : 994 - 994
  • [22] Perioperative and oncologic outcomes of hepatic arterial infusion pump chemotherapy for patients with unresectable colorectal liver metastases at an expanding HAI program
    Liu, Annie
    Lowe, Melissa
    Niedzwiecki, Donna
    Kramer, Ryan
    Medina, Cathlyn
    Rhodin, Kristen E.
    Sharib, Jeremy
    Creasy, John
    Wildman-Tobriner, Benjamin
    Abbruzzese, James
    Griffie, Deanna
    Strickler, John
    Hsu, David
    Nussbaum, Daniel
    Zani, Sabino
    Uronis, Hope E.
    Allen, Peter J.
    Lidsky, Michael
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S179 - S180
  • [23] A RANDOMIZED STUDY OF HEPATIC ARTERIAL INFUSION (HAI) OF 5-FLUOROURACIL (5-FU) WITH OR WITHOUT HEPATIC IRRADIATION (HXR) IN THE TREATMENT OF LIVER METASTASES FROM COLORECTAL-CARCINOMA
    THIRLWELL, M
    BOOS, G
    HAZEL, J
    HERBA, M
    BOILEAU, G
    HOLLINGSWORTH, L
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1985, 8 (03): : A168 - A168
  • [24] Hepatic arterial infusion (HAI) of oxaliplatin with capecitabine in first line treatment of patients (pts) with liver limited metastases from colorectal cancer (LLmCRC)
    Vittrup, B. V.
    Norgaard, H. H.
    Bergenfeldt, M.
    Larsen, F. O.
    Hogdall, E.
    Johansen, J. S.
    Johansen, J. S. Sidenius
    Hermann, H. K.
    Nielsen, D. L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [25] Identification of patients who most benefit from hepatic arterial infusion (HAI) combined or not with systemic chemotherapy for the treatment of unresectable colorectal liver metastases
    Pilati, P.
    Mocellin, S.
    Lise, M.
    Nitti, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases
    Apostolia M. Tsimberidou
    Yang Ye
    Jennifer Wheler
    Aung Naing
    David Hong
    Uchechi Nwosu
    Kenneth R. Hess
    Robert A. Wolff
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 955 - 963
  • [27] A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases
    Tsimberidou, Apostolia M.
    Ye, Yang
    Wheler, Jennifer
    Naing, Aung
    Hong, David
    Nwosu, Uchechi
    Hess, Kenneth R.
    Wolff, Robert A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 955 - 963
  • [28] Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: A phase I-II clinical study
    Fiorentini, G
    Rossi, S
    Dentico, P
    Meucci, F
    Bonechi, F
    Bernardeschi, P
    Cantore, M
    Guadagni, S
    De Simone, M
    ANTICANCER RESEARCH, 2004, 24 (3B) : 2093 - 2096
  • [29] Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer
    Mocellin, S.
    Pasquali, S.
    Nitti, D.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (03):
  • [30] Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer
    Kemeny, N
    Gonen, M
    Sullivan, D
    Schwartz, L
    Benedetti, F
    Saltz, L
    Stockman, J
    Fong, Y
    Jarnagin, W
    Bertino, J
    Tong, W
    Paty, P
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) : 2687 - 2695
12345